Niloofar Rahmani

Array ( [id] => 6144778 [patent_doc_number] => 20110130406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-02 [patent_title] => 'PYRAZOLO-PYRIDINES AS TYROSINE KINASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/676790 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41037 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20110130406.pdf [firstpage_image] =>[orig_patent_app_number] => 12676790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324342 [patent_doc_number] => 20090062332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Disubstituted alkyl-8-azabicyclo[3.2.1] octane compounds as mu opioid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/229636 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19863 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062332.pdf [firstpage_image] =>[orig_patent_app_number] => 12229636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858641 [patent_doc_number] => 08461177 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Antiviral drugs for treatment of arenavirus infection' [patent_app_type] => utility [patent_app_number] => 12/673983 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14331 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12673983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5291040 [patent_doc_number] => 20090023770 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Novel 1,2,3-Substituted Indolizine Derivatives, Inhibitors of FGFs, Method for Preparing Them and Pharmaceutical Compositions Containing Them' [patent_app_type] => utility [patent_app_number] => 12/198545 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19896 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20090023770.pdf [firstpage_image] =>[orig_patent_app_number] => 12198545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5453282 [patent_doc_number] => 20090069319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'IMIDAZOPYRIDINE ANALOGS AND THEIR USE AS AGONISTS OF THE WNT-BETA-CATENIN CELLULAR MESSAGING SYSTEM' [patent_app_type] => utility [patent_app_number] => 12/198354 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31819 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20090069319.pdf [firstpage_image] =>[orig_patent_app_number] => 12198354 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324343 [patent_doc_number] => 20090062333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => '8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/229664 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18998 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062333.pdf [firstpage_image] =>[orig_patent_app_number] => 12229664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324344 [patent_doc_number] => 20090062334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/229737 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20610 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062334.pdf [firstpage_image] =>[orig_patent_app_number] => 12229737 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324345 [patent_doc_number] => 20090062335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists' [patent_app_type] => utility [patent_app_number] => 12/229748 [patent_app_country] => US [patent_app_date] => 2008-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18886 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062335.pdf [firstpage_image] =>[orig_patent_app_number] => 12229748 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324300 [patent_doc_number] => 20090062290 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'HETEROCYCLES AS POTASSIUM CHANNEL MODULATORS' [patent_app_type] => utility [patent_app_number] => 12/193639 [patent_app_country] => US [patent_app_date] => 2008-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42533 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062290.pdf [firstpage_image] =>[orig_patent_app_number] => 12193639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123559 [patent_doc_number] => 07705147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Indole derivatives as selective androgen receptor modulators (SARMS)' [patent_app_type] => utility [patent_app_number] => 12/188586 [patent_app_country] => US [patent_app_date] => 2008-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41115 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/705/07705147.pdf [firstpage_image] =>[orig_patent_app_number] => 12188586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792741 [patent_doc_number] => 20080293715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Therapeutic Pyrazolo[3,4-b]Pyridines and Indazoles' [patent_app_type] => utility [patent_app_number] => 12/185419 [patent_app_country] => US [patent_app_date] => 2008-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 36500 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293715.pdf [firstpage_image] =>[orig_patent_app_number] => 12185419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560327 [patent_doc_number] => 08334390 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Fungicide N-cycloalkyl-N-bicyclic-carboxamide derivatives' [patent_app_type] => utility [patent_app_number] => 12/452887 [patent_app_country] => US [patent_app_date] => 2008-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13864 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12452887 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4484925 [patent_doc_number] => 07902227 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents' [patent_app_type] => utility [patent_app_number] => 12/180641 [patent_app_country] => US [patent_app_date] => 2008-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19524 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902227.pdf [firstpage_image] =>[orig_patent_app_number] => 12180641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4950149 [patent_doc_number] => 20080306275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'NOVEL HETEROARYL DERIVATIVE' [patent_app_type] => utility [patent_app_number] => 12/173792 [patent_app_country] => US [patent_app_date] => 2008-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30577 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306275.pdf [firstpage_image] =>[orig_patent_app_number] => 12173792 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6635393 [patent_doc_number] => 20100226881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'PYRAZOLO[1,5-a]PYRIDINES AND THEIR USE IN CANCER THERAPY' [patent_app_type] => utility [patent_app_number] => 12/452536 [patent_app_country] => US [patent_app_date] => 2008-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45718 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226881.pdf [firstpage_image] =>[orig_patent_app_number] => 12452536 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4534655 [patent_doc_number] => 07888358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => '8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors' [patent_app_type] => utility [patent_app_number] => 12/216213 [patent_app_country] => US [patent_app_date] => 2008-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13155 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 901 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888358.pdf [firstpage_image] =>[orig_patent_app_number] => 12216213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6508628 [patent_doc_number] => 20100210644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-19 [patent_title] => 'CHEMICAL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/665822 [patent_app_country] => US [patent_app_date] => 2008-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10853 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20100210644.pdf [firstpage_image] =>[orig_patent_app_number] => 12665822 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515464 [patent_doc_number] => 20090215771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'JNK INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/143231 [patent_app_country] => US [patent_app_date] => 2008-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29474 [patent_no_of_claims] => 102 [patent_no_of_ind_claims] => 67 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215771.pdf [firstpage_image] =>[orig_patent_app_number] => 12143231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853200 [patent_doc_number] => 20080318943 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Compounds and Uses Thereof - 848' [patent_app_type] => utility [patent_app_number] => 12/141190 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 94010 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0318/20080318943.pdf [firstpage_image] =>[orig_patent_app_number] => 12141190 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5350049 [patent_doc_number] => 20090005410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'N-(2-(HETARYL)ARYL) ARYLSULFONAMIDES AND N-(2-(HETARYL) HETARYL ARYLSULFONAMIDES' [patent_app_type] => utility [patent_app_number] => 12/140593 [patent_app_country] => US [patent_app_date] => 2008-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33195 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005410.pdf [firstpage_image] =>[orig_patent_app_number] => 12140593 [rel_patent_id] =>[rel_patent_doc_number] =>)